Literature DB >> 28958446

Middle East respiratory syndrome coronavirus transmission among health care workers: Implication for infection control.

Sarah H Alfaraj1, Jaffar A Al-Tawfiq2, Talal A Altuwaijri3, Marzouqa Alanazi4, Nojoom Alzahrani5, Ziad A Memish6.   

Abstract

BACKGROUND: Many outbreaks of Middle East respiratory syndrome coronavirus (MERS-CoV) have occurred in health care settings and involved health care workers (HCWs). We describe the occurrence of an outbreak among HCWs and attempt to characterize at-risk exposures to improve future infection control interventions.
METHODS: This study included an index case and all HCW contacts. All contacts were screened for MERS-CoV using polymerase chain reaction.
RESULTS: During the study period in 2015, the index case was a 30-year-old Filipino nurse who had a history of unprotected exposure to a MERS-CoV-positive case on May 15, 2015, and had multiple negative tests for MERS-CoV. Weeks later, she was diagnosed with pulmonary tuberculosis and MERS-CoV infection. A total of 73 staff were quarantined for 14 days, and nasopharyngeal swabs were taken on days 2, 5, and 12 postexposure. Of those contacts, 3 (4%) were confirmed positive for MERS-CoV. An additional 18 staff were quarantined and had MERS-CoV swabs. A fourth case was confirmed positive on day 12. Subsequent contact investigations revealed a fourth-generation transmission. Only 7 (4.5%) of the total 153 contacts were positive for MERS-CoV.
CONCLUSIONS: The role of HCWs in MERS-CoV transmission is complex. Although most MERS-CoV-infected HCWs are asymptomatic or have mild disease, fatal infections can occur and HCWs can play a major role in propagating health care facility outbreaks. This investigation highlights the need to continuously review infection control guidance relating to the role of HCWs in MERS-CoV transmission in health care outbreaks, especially as it relates to the complex questions on definition of risky exposures, who to test, and the frequency of MERS-CoV testing; criteria for who to quarantine and for how long; and clearance and return to active duty criteria.
Copyright © 2018 Association for Professionals in Infection Control and Epidemiology, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Infection control; MERS-CoV; Middle East respiratory syndrome coronavirus; Outbreak

Mesh:

Year:  2017        PMID: 28958446      PMCID: PMC7115310          DOI: 10.1016/j.ajic.2017.08.010

Source DB:  PubMed          Journal:  Am J Infect Control        ISSN: 0196-6553            Impact factor:   2.918


Since the emergence of Middle East respiratory syndrome coronavirus (MERS-CoV) in September 2012, the largest and most documented outbreaks to date have occurred in health care settings.1, 2, 3, 4, 5, 6 As of June 26, 2017, there have been 2,029 cases, including a total of 704 deaths, reported to the World Health Organization. The recent outbreaks of MERS-CoV infection highlight the importance of the emergency departments in being the initial site of the spread of this virus.8, 9, 10, 11, 12 In addition, hemodialysis units were also highlighted as the focus of multiple documented and undocumented outbreaks in Al-Hasa and Taif, Saudi Arabia (SA).5, 13 From April 2014-November 2016, a total of 295 confirmed cases were admitted to Prince Mohamed Bin Abdulaziz Hospital (PMAH), Ministry of Health, Riyadh, SA. Of those cases, 98 (33%) were diagnosed at PMAH, whereas the rest were transferred to PMAH from other Riyadh hospitals, because it is the reference coronavirus center for the central region of SA. Here, we describe a detailed investigation of an outbreak of MERS-CoV among health care workers (HCWs) in a MERS-CoV referral hospital with key learning points to be highlighted.

Methods

We describe the transmission pattern and contact tracing of a MERS-CoVinfected HCW, resulting in an outbreak in PMAH in SA. All suspected HCWs were tested for MERS-COV using real-time polymerase chain reaction. The target upstream of MERS-CoV was upE and ORF1a. The first case who initiated the outbreak was designated as the index case with all her positive contacts designated as primary transmissions. As described previously, subsequent cases resulting from the first-generation cases were called second-generation transmission, and infected HCWs from those were designated as third-generation cases and so on.

Results

Index case

The case was confirmed on August 12, 2015 (from the first screening swab), and the patient was a 30-year-old Filipino nurse who had a history of unprotected exposure to a MERS-CoV–positive case on May 15, 2015. She was normal weight (weight, 58 kg). At that time and as per hospital protocol, she was quarantined for 14 days. MERS-CoV swab was documented on days 2, 5, and 12 to be negative (May 17, 23, and 27). On June 26, she went on vacation to the Philippines. Two weeks after her arrival to the Philippines, she manifested symptoms of dry cough and shortness of breath. She self-medicated herself with amoxicillin with no significant improvement. On August 7, she came back to SA, and on August 10, she was seen at the employee health clinic for evaluation. Given her recent arrival from a nonendemic country, screening for MERS-CoV was not considered. On August 11, she was allowed to resume work despite being symptomatic with dry cough and shortness of breath. On August 12, she was admitted as a suspected tuberculosis vs MERS-CoV infection. On the following day, MERS-CoV test was positive (cycle threshold [Ct] values of upE gene = 35, and ORF1a gene = 34), and she also tested positive for tuberculosis.

Contacts of the index case

A comprehensive contact tracing was done, with a total of 73 staff quarantined for 14 days, and nasopharyngeal swabs taken on days 2, 5, and 12 postexposure. All quarantined HCW contacts had daily monitoring for fever and respiratory symptoms. Of those contacts, 3 (4%) were asymptomatic and confirmed positive for MERS-CoV by nasopharyngeal swabs (on first swab). An additional 18 new HCW contacts were quarantined and had MERS-CoV swabs as previously indicated. A fourth case was asymptomatic and tested negative on days 2 and 5 but was confirmed positive on day 12. Therefore, an additional 7 staff were quarantined (the fourth case's flatmates). A fifth staff member had fever and sore throat and was confirmed positive on first swab, and she came into contact with 15 additional staff. A sixth case had cough and sore throat and was confirmed positive on third swab. This sixth case had 21 additional contacts. Of those, 1 nurse was diagnosed with MERS-CoV (seventh case). The staff member was asymptomatic and was positive on the first swab. The seventh case had an additional 22 exposed staff, but none of them were positive (Fig 1 ). Therefore, only 7 (4.5%) of the total 153 contacts were positive for MERS-CoV.
Fig 1

Graphical representation of the evolution of the outbreak.

Graphical representation of the evolution of the outbreak. All confirmed cases were nurses, and 2 of the 7 subsequent cases were thought to acquire the infection through an exposure within the housing compound. Detailed questioning on the significance of the contact with the positive cases revealed the following: 3 (43%) had contact <1.5 m, 4 (57%) had contact for <10 minutes, 3 (43%) had contact <1.5 m and >10 minutes, and the remaining had contact >1.5 m and <10 minutes (Table 1 ). Only the index case had an abnormal chest radiograph, and the laboratory evaluations of all positive cases are shown in Table 2 . All positive cases were positive on the first swab except for 2 who were positive on the second and third swabs. The mean time to negative swab was 4.8 days (range, 2-14 days).
Table 1

Characteristics of confirmed MERS-CoV cases

No.SexAge (y)NationalitySymptomsDays to negativeNo. of contactsDistance of contact (m)Duration (min)DepartmentLOS (d)
IndexF30FilipinoCough, SOB279>1.5<10ICU32
1F37FilipinoAsymptomatic45<1.5>10ICU10
2F28FilipinoAsymptomatic47>1.5<10ICU10
3F28IndianAsymptomatic46>1.5<10ICU12
4F26FilipinoAsymptomatic20<1.5>10ICU14
5F27FilipinoFever, sore throat321>1.5<10Ward 2416
6F29FilipinoCough, sore throat1415>1.5<10Ward 1214
7M30JordanianAsymptomatic620<1.5>10Ward 2412

F, female; ICU, intensive care unit; LOS, length of stay; M, male; MERS-CoV, Middle East respiratory syndrome coronavirus.

Table 2

Laboratory data of confirmed MERS-CoV cases

No.WBCS × 109/LHgb (g/L)PLAT × 109/LNEUT no. × 109/LNEUT (%)CK (100 U/L)ALT (13 U/L)AST (29 U/L)Creatinine, (µmol/L)Albumin (33 g/L)
Index6.81333304.769NANANA61NA
181402055.3770131533263.943
210156360NANANA142067.149
312.2119206NANANA282148.334
491503016.3571NA233250.245
517.714616615.386NA192068.145
6131534398.2664NANANANANA
75.21591812.8955NA202171.844

ALT, alanine aminotransferase; AST, aspartate aminotransferase; CK, creatinine kinase; Hgb, hemoglobin; MERS-CoV, Middle East respiratory syndrome coronavirus; NA, not applicable; NEUT, neutrophil; PLAT, platelet; SOB, shortness of breath; WBC, white blood cell count.

Characteristics of confirmed MERS-CoV cases F, female; ICU, intensive care unit; LOS, length of stay; M, male; MERS-CoV, Middle East respiratory syndrome coronavirus. Laboratory data of confirmed MERS-CoV cases ALT, alanine aminotransferase; AST, aspartate aminotransferase; CK, creatinine kinase; Hgb, hemoglobin; MERS-CoV, Middle East respiratory syndrome coronavirus; NA, not applicable; NEUT, neutrophil; PLAT, platelet; SOB, shortness of breath; WBC, white blood cell count.

Discussion

In this outbreak investigation, we report 4 generations of transmission of MERS-CoV among HCWs. The transmission dynamics suggest that the transmission occurred within the setting of the hospital and in the housing environment. These findings highlight the importance of continued vigilance and detailed systematic screening of exposed HCWs whether they are symptomatic or not. Such an activity is very complex, and often it is difficult to elucidate the exact contact pattern between HCWs because of the extensive social interaction within the hospital and housing among different HCWs from different units. In addition, there are difficulties in relying on HCW's memory of exact contacts and infection control precautions taken during that contact. The index case was initially identified as a contact of a MERS-CoV patient, and she had multiple swabs that were negative. She then went to the Philippines and started to have symptoms. Later, she was diagnosed with both MERS-CoV and pulmonary tuberculosis. Because the diagnosis of MERS had occurred many weeks after several negative MERS swabs, the exact source of the infection could not be determined. In the South Korean MERS-CoV outbreak, 5 patients with MERS-CoV had unclear infection sources. During the outbreak investigation, there were 4 spreaders (transmitting MERS to ≥1 individuals), and 1 possibly was a superspreader (transmitted the virus to 4 HCWs). In the South Korean outbreak, superspreader was arbitrarily defined as transmission of MERS-CoV to ≥5 cases. However, the exact definition of superspreader is not well established. The characteristics of the index case of an infectious disease outbreak potentially influence the transmission dynamics. These dynamics may also depend on the traits of the individuals with whom the index case interacts. In this investigation, we found that all HCWs were nursing staff. In a previous outbreak study, none of the neurology unit workers contracted MERS-CoV, but 15 medical workers (11.7%) and 5 emergency department workers (4.1%) did contract MERS-CoV. The seropositivity of HCWs after a contact with MERS-CoV patients is variable. In this study, the polymerase chain reaction positivity rate was 4.5% among the exposed staff and no serologic testing was conducted. In a previous study of 1,169 HCWs, 15 were positive by polymerase chain reaction and 5 of 737 HCWs were positive by serology testing. In a second study from Thailand, none of 38 HCWs tested positive by serology. Using serology, none of 48 contacts were positive for MERS-CoV infection. In Korea, 36 (19.9%) of 181 confirmed MERS-CoV cases were HCWs. Although MERS-CoV among HCWs is usually asymptomatic or presents as a mild disease, fatal cases had been reported. Comparing MERS-CoV with severe acute respiratory syndrome (SARS), most HCWs with SARS had symptomatic infection with an associated high case fatality rate. In one study, the case fatality rate was 7% among MERS-CoVinfected HCWs versus 12% in SARS among HCWs. The current study showed that most of the MERS-CoV–positive HCWs had asymptomatic or mild disease consistent with previous observations. What is surprising in our report was the fact that asymptomatic HCWs were able to transmit the virus to other HCWs despite being asymptomatic. This is in sharp contrast with the recent report from South Korea were none of 82 contacts of asymptomatic patients turned out to be positive. Although, the Ct value of the index case was high, the index case was able to infect an additional 4 cases. The relationship between the Ct value and transmission dynamics was not studied. However, a lower Ct of 31 for E gene was significantly lower than the median of 33 of survivors. Systematic thorough screening for MERS-CoV among contacts is needed for effective infection control of outbreaks. The current guidelines from the Saudi Ministry of Health do not advocate routine MERS-CoV testing of asymptomatic contacts and advocate the return to normal duty. However, the guidelines stress the need for testing of all the HCWs involved in high-risk unprotected exposure. High-risk exposure is defined as “contact with confirmed MERS-CoV case within 1.5 meters for > 10 minutes.” Those who are asymptomatic should have only 1 test. The Centers for Disease Control and Prevention recommends that asymptomatic HCWs do not get routine MERS-CoV testing. During an outbreak investigation, HCWs with no symptoms were allowed to work with active monitoring and to be excluded from work if they develop MERS-CoV–like symptoms. The index case acquired MERS-CoV from the community, and she had concomitant tuberculosis with MERS-CoV. The coinfection might have contributed to increased infectiveness because of coughing and damaged lung tissue. The World Health Organization recommends testing all contacts in health care–associated outbreaks regardless of the development of symptoms. In addition, the World Health Organization recommends that asymptomatic HCWs with positive MERS-CoV by polymerase chain reaction should be isolated. The HCWs can return to work when 2 consecutive upper respiratory tract samples taken at least 24 hours apart are negative on real-time polymerase chain reaction. In this study, 43% had contact <1.5 m, 57% had contact <10 minutes, and 43% had high-risk contact (<1.5 m and >10 minutes contact). Therefore, of those positive, only 43% had high-risk exposure. Therefore, this definition alone may not be sufficient to exclude HCWs from testing. In a study of 9 HCWs who had contact within 0.91-1.83 meters of a MERS-CoV patient, only 1 of them was positive for MERS-CoV. In another study, all HCWs' contacts reported 100% compliance with personal protective equipment, and none were positive. In a study of 48 HCWs' contacts, none had serologic evidence of MERS-CoV infection. However, the largest screening of MERS-CoV among HCWs showed a positive rate of 1.1% among 1,695 HCWs. In the SARS era, asymptomatic patients were culture negative for SARS. Therefore, it is not clear if asymptomatic MERS-CoV patients behave similarly to SARS patients. In conclusion, all HCWs in contact with confirmed MERS-CoV patients need to be quarantined for 14 days no matter how significant the contact is, if the full compliance with personal protective equipment cannot be assured with certainty. One and 2 samplings might not be adequate, and a third sampling is advisable prior to HCW clearance. The current detailed investigation identified positive contacts of asymptomatic MERS-CoV–positive HCWs, which highlights the possibility of being infectious even if symptoms are lacking, a question which has been debated by scientists for years.
  28 in total

1.  Novel coronavirus spreads to Tunisia.

Authors:  Anne Gulland
Journal:  BMJ       Date:  2013-05-23

2.  Control of an Outbreak of Middle East Respiratory Syndrome in a Tertiary Hospital in Korea.

Authors:  Ga Eun Park; Jae-Hoon Ko; Kyong Ran Peck; Ji Yeon Lee; Ji Yong Lee; Sun Young Cho; Young Eun Ha; Cheol-In Kang; Ji-Man Kang; Yae-Jean Kim; Hee Jae Huh; Chang-Seok Ki; Nam Yong Lee; Jun Haeng Lee; Ik Joon Jo; Byeong-Ho Jeong; Gee Young Suh; Jinkyeong Park; Chi Ryang Chung; Jae-Hoon Song; Doo Ryeon Chung
Journal:  Ann Intern Med       Date:  2016-05-31       Impact factor: 25.391

3.  Hospital outbreak of Middle East respiratory syndrome coronavirus.

Authors:  Abdullah Assiri; Allison McGeer; Trish M Perl; Connie S Price; Abdullah A Al Rabeeah; Derek A T Cummings; Zaki N Alabdullatif; Maher Assad; Abdulmohsen Almulhim; Hatem Makhdoom; Hossam Madani; Rafat Alhakeem; Jaffar A Al-Tawfiq; Matthew Cotten; Simon J Watson; Paul Kellam; Alimuddin I Zumla; Ziad A Memish
Journal:  N Engl J Med       Date:  2013-06-19       Impact factor: 91.245

4.  Multifacility Outbreak of Middle East Respiratory Syndrome in Taif, Saudi Arabia.

Authors:  Abdullah Assiri; Glen R Abedi; Abdulaziz A Bin Saeed; Mutwakil A Abdalla; Malak al-Masry; Abdul Jamil Choudhry; Xiaoyan Lu; Dean D Erdman; Kathleen Tatti; Alison M Binder; Jessica Rudd; Jerome Tokars; Congrong Miao; Hussain Alarbash; Randa Nooh; Mark Pallansch; Susan I Gerber; John T Watson
Journal:  Emerg Infect Dis       Date:  2016-01       Impact factor: 6.883

5.  Infectivity of an Asymptomatic Patient With Middle East Respiratory Syndrome Coronavirus Infection.

Authors:  Soo-Youn Moon; Jun Seong Son
Journal:  Clin Infect Dis       Date:  2017-05-15       Impact factor: 9.079

6.  Surveillance of the Middle East respiratory syndrome (MERS) coronavirus (CoV) infection in healthcare workers after contact with confirmed MERS patients: incidence and risk factors of MERS-CoV seropositivity.

Authors:  C-J Kim; W S Choi; Y Jung; S Kiem; H Y Seol; H J Woo; Y H Choi; J S Son; K-H Kim; Y-S Kim; E S Kim; S H Park; J H Yoon; S-M Choi; H Lee; W S Oh; S-Y Choi; N-J Kim; J-P Choi; S Y Park; J Kim; S J Jeong; K S Lee; H C Jang; J Y Rhee; B-N Kim; J H Bang; J H Lee; S Park; H Y Kim; J K Choi; Y-M Wi; H J Choi
Journal:  Clin Microbiol Infect       Date:  2016-07-27       Impact factor: 8.067

7.  Middle East Respiratory Syndrome Coronavirus and Pulmonary Tuberculosis Coinfection: Implications for Infection Control.

Authors:  Sarah H Alfaraj; Jaffar A Al-Tawfiq; Talal A Altuwaijri; Ziad A Memish
Journal:  Intervirology       Date:  2017-07-06       Impact factor: 1.763

8.  Detection of SARS coronavirus in patients with suspected SARS.

Authors:  Kwok H Chan; Leo L L M Poon; V C C Cheng; Yi Guan; I F N Hung; James Kong; Loretta Y C Yam; Wing H Seto; Kwok Y Yuen; Joseph S Malik Peiris
Journal:  Emerg Infect Dis       Date:  2004-02       Impact factor: 6.883

9.  Clinical features and viral diagnosis of two cases of infection with Middle East Respiratory Syndrome coronavirus: a report of nosocomial transmission.

Authors:  Benoit Guery; Julien Poissy; Loubna el Mansouf; Caroline Séjourné; Nicolas Ettahar; Xavier Lemaire; Fanny Vuotto; Anne Goffard; Sylvie Behillil; Vincent Enouf; Valérie Caro; Alexandra Mailles; Didier Che; Jean-Claude Manuguerra; Daniel Mathieu; Arnaud Fontanet; Sylvie van der Werf
Journal:  Lancet       Date:  2013-05-30       Impact factor: 79.321

10.  Description of a Hospital Outbreak of Middle East Respiratory Syndrome in a Large Tertiary Care Hospital in Saudi Arabia.

Authors:  Hanan H Balkhy; Thamer H Alenazi; Majid M Alshamrani; Henry Baffoe-Bonnie; Yaseen Arabi; Raed Hijazi; Hail M Al-Abdely; Aiman El-Saed; Sameera Al Johani; Abdullah M Assiri; Abdulaziz Bin Saeed
Journal:  Infect Control Hosp Epidemiol       Date:  2016-07-18       Impact factor: 3.254

View more
  28 in total

Review 1.  Prospects for a MERS-CoV spike vaccine.

Authors:  Yusen Zhou; Shibo Jiang; Lanying Du
Journal:  Expert Rev Vaccines       Date:  2018-08-09       Impact factor: 5.217

Review 2.  An Opportunistic Pathogen Afforded Ample Opportunities: Middle East Respiratory Syndrome Coronavirus.

Authors:  Ian M Mackay; Katherine E Arden
Journal:  Viruses       Date:  2017-12-02       Impact factor: 5.048

3.  Nosocomial outbreak of the Middle East Respiratory Syndrome coronavirus: A phylogenetic, epidemiological, clinical and infection control analysis.

Authors:  Mazin Barry; My Vt Phan; Layan Akkielah; Fahad Al-Majed; Abdulkarim Alhetheel; Ali Somily; Sarah Suliman Alsubaie; Scott Jn McNabb; Matthew Cotten; Alimuddin Zumla; Ziad A Memish
Journal:  Travel Med Infect Dis       Date:  2020-06-27       Impact factor: 6.211

Review 4.  COVID-19 outbreak and endoscopy: Considerations in patients encountered in a foregut surgery practice.

Authors:  Tanya Olszewski; Andrew D Grubic; Shahin Ayazi; Blair A Jobe
Journal:  World J Gastrointest Surg       Date:  2020-05-27

5.  Middle East Respiratory Syndrome Coronavirus (MERS-CoV) in Oman: Current Situation and Going Forward.

Authors:  Salah T Al Awaidy; Faryal Khamis
Journal:  Oman Med J       Date:  2019-05

6.  High Prevalence of MERS-CoV Infection in Camel Workers in Saudi Arabia.

Authors:  Abeer N Alshukairi; Jian Zheng; Jingxian Zhao; Jincun Zhao; Stanley Perlman; Abdulaziz N Alagaili; Atef Nehdi; Salim A Baharoon; Laila Layqah; Ahmad Bokhari; Sameera M Al Johani; Nosaibah Samman; Mohamad Boudjelal; Patrick Ten Eyck; Maha A Al-Mozaini
Journal:  mBio       Date:  2018-10-30       Impact factor: 7.867

7.  Infectious MERS-CoV Isolated From a Mildly Ill Patient, Saudi Arabia.

Authors:  Hail M Al-Abdely; Claire M Midgley; Abdulrahim M Alkhamis; Glen R Abedi; Azaibi Tamin; Alison M Binder; Khalid Alanazi; Xiaoyan Lu; Osman Abdalla; Senthilkumar K Sakthivel; Mutaz Mohammed; Krista Queen; Homoud S Algarni; Yan Li; Suvang Trivedi; Abdullah Algwizani; Raafat F Alhakeem; Natalie J Thornburg; Suxiang Tong; Sameeh S Ghazal; Dean D Erdman; Abdullah M Assiri; Susan I Gerber; John T Watson
Journal:  Open Forum Infect Dis       Date:  2018-05-15       Impact factor: 3.835

8.  Middle East Respiratory Syndrome Coronavirus and the One Health concept.

Authors:  Maged Gomaa Hemida
Journal:  PeerJ       Date:  2019-08-22       Impact factor: 2.984

Review 9.  Middle East respiratory syndrome.

Authors:  Ziad A Memish; Stanley Perlman; Maria D Van Kerkhove; Alimuddin Zumla
Journal:  Lancet       Date:  2020-03-04       Impact factor: 79.321

Review 10.  Features of enteric disease from human coronaviruses: Implications for COVID-19.

Authors:  Nevio Cimolai
Journal:  J Med Virol       Date:  2020-06-05       Impact factor: 20.693

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.